Immunotherapy in Glioblastoma: An Overview of Current Status

Clinical Pharmacology: Advances and Applications · Published 2025-07-01 · DOI 10.2147/cpaa.s497903

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/cpaa.s497903

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression · Cancer Immunology, Immunotherapy · 2022 · Cites or is cited by this article
• Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban · Clinical Pharmacology: Advances and Applications · 2021 · Same journal
• A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter] · Clinical Pharmacology: Advances and Applications · 2022 · Same journal
• Hybrid Hydrogels in Pain Management Application: A Comprehensive Review · Clinical Pharmacology: Advances and Applications · 2026 · Same journal
• Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation · Clinical Pharmacology: Advances and Applications · 2023 · Same journal
• Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions · Clinical Pharmacology: Advances and Applications · 2025 · Same journal
• Allopurinol-Induced Stevens–Johnson Syndrome (SJS) · Clinical Pharmacology: Advances and Applications · 2023 · Same journal
• Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience · Clinical Pharmacology: Advances and Applications · 2021 · Same journal
• Optimizing Antimicrobial Use in Japan: Strategies for Dosage, Combination Therapy, De-Escalation, Oral Switching, Duration, and Guideline Adherence · Clinical Pharmacology: Advances and Applications · 2025 · Same journal
• Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy · Clinical Pharmacology: Advances and Applications · 2025 · Same journal